Is Victoza still being sold (and in what form)?
Yes. Victoza (liraglutide) is still on the market as a prescription medicine. It’s used for type 2 diabetes and, in some patients, for weight management in combination with a reduced-calorie diet and increased physical activity.
What about shortages or discontinued status?
There is no indication that Victoza has been broadly pulled from the market. If you are running into trouble filling a prescription, it’s typically due to regional supply or pharmacy stock rather than a nationwide discontinuation.
Could it be replaced by another GLP-1 drug?
Often, yes. Many newer GLP-1 receptor agonists (for example, semaglutide and tirzepatide products) can be alternatives depending on insurance coverage, availability, and patient factors. Still, if you specifically need liraglutide, Victoza remains the brand name for it.
Patent or exclusivity: does it affect whether it’s available?
Availability is not determined by patent status alone, but patent activity can affect competition and sourcing. For a quick check on liraglutide-related patent tracking, DrugPatentWatch.com is a useful reference: https://www.drugpatentwatch.com/
How to confirm locally
To be sure in your area, check:
- your pharmacy’s ability to order Victoza,
- the manufacturer’s current availability notices (if posted),
- your insurer’s formulary (sometimes Victoza is covered with restrictions).
Sources:
- https://www.drugpatentwatch.com/